Actively Recruiting

Age: 18Years +
All Genders
ID06807853

Symptom Assessment in Axial Spondyloarthritis Using Patient-Reported Outcomes and Smartwatch Mobility Tracking to Develop Movement Recommendations

Led by University of Bonn · Updated on 2025-02-18

50

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

U

University of Bonn

Lead Sponsor

N

Novartis

Collaborating Sponsor

AI-Summary

What this Trial Is About

Axial spondyloarthritis (axSpa) is a chronic autoimmune disease affecting the back, causing pain, reduced function, and lower quality of life. Despite treatments like biological agents, only about 25% of patients reach remission. Physical activity plays an important role in controlling the disease, but daily movement patterns are not yet tracked in clinical practice. This study aims to analyze how different types, frequencies, and intensities of movement affect disease control and to develop clear movement recommendations for patients with axSpa. This is a monocentric longitudinal observational study where 50 participants with axSpa will be monitored over 6 months. Movement, physical activity, heart rate, and heart rate variability data are collected continuously using an AppleWatch SE smartwatch paired with a specially designed study app on the participant's own iPhone. Every two weeks, patients complete surveys about disease activity, pain, and function. Patients visit the clinic every 3 months for physical exams and assessments. Data from the smartwatch and surveys will be analyzed to create specific movement recommendations. Participants will wear the smartwatch and use the app to track activity and report symptoms throughout the 6-month study. Clinical visits occur every 3 months for examinations and medical history updates. Researchers measure outcomes such as daily steps, training and standing time, average heart rate, heart rate variability, pain levels, and disease activity. The goal is to provide concrete advice on movement to help manage axSpa symptoms, prevent flares, and improve recovery. The total participation time is 6 months with data collected continuously and surveys completed biweekly.

CONDITIONS

Brief Title

A LONGITUDINAL OBSERVATIONAL STUDY to EVALUATE the EFFICACY of MOVEMENT and IMPLEMENT CONCRETE MOVEMENT RECOMMENDATIONS with the HELP of MOBILITY TRACKING with SMARTWATCHES in SUBJECTS with AXIAL SPONDYLOARTHRITIS

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients with axial spondyloarthritis
  • Own an iPhone to use the study app
  • Willing and able to wear a smartwatch regularly
  • Able to complete patient-reported outcome surveys at home regularly
Not Eligible

You will not qualify if you...

  • Do not have an iPhone
  • Unable to wear a smartwatch due to physical or mental reasons
  • Unable to complete patient-reported outcome surveys at home due to physical or mental reasons

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person or remote)

Monitoring

Duration - 24 weeks

Participants wear a smartwatch to track mobility and complete patient-reported outcome surveys at home regularly to evaluate movement and symptoms.

Continuous monitoring with smartwatch and regular remote surveys

Trial Site Locations

Total: 1 location

1

University Hospital, Department for Rheumatology

Bonn, North Rhine-Westphalia, Germany, 53127

Actively Recruiting

Loading map...

Research Team

P

Prof. Dr. med. Valentin S. Schaefer

D

Dr. med. Lena Hatzmann

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Similar Trials

A Multicenter Open-label, Prospective Study to Assess the Co...

Moderate to Severe Plaque Psoriasis

Actively Recruiting

12 locations

A Multicenter, Randomized, Double-blind, Placebo-controlled,...

Axial Spondyloarthritis

Actively Recruiting

6 locations

An Open-label, Randomized Study to Compare Bimekizumab Given...

Psoriatic Arthritis

Actively Recruiting

61 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here